Looking ahead, analysts said a temporary breather cannot be ruled out, with immediate support placed around 24,900–25,000. However, the upside is likely to stay capped until private banks and IT show signs of recovery.
In today’s trade, shares of Glenmark Pharma, Adani Energy, Dr Reddy’s, Tata Motors, Newgen Software among others will be in focus due to various news developments.
Glenmark Pharma
Glenmark Pharmaceuticals announced signing of an exclusive licence and collaboration pact with Hengrui Pharma for development and commercialisation of Trastuzumab Rezetecan that is aimed at treating different types of cancer. The company’s arm Glenmark Specialty SA has entered into an exclusive licence and collaboration agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811).
Adani Energy Solutions
Adani Energy Solutions (AESL) said that all its operational sites and corporate headquarters have received the ‘Zero-Waste-to-Landfill’ (ZWL) certification from Intertek, a global quality assurance provider. The company stated that it achieved a 100% diversion rate, with zero waste sent to landfills. As per a media release by AESL, the certification means that all waste generated at its facilities is managed through reduction, reuse, recycling, or recovery, ensuring that none of it ends up in landfills.
Poly Medicure
Medical device maker Poly Medicure said it will fully acquire Italy-based Citieffe Group at an enterprise value of Rs 324 crore (EUR 31 million). The company has signed a definitive agreement to acquire 100 per cent stake in Medistream SA (Group) consisting of Citieffe SRL and its step-down subsidiaries in USA & Mexico, the company said in a statement.Dr Reddy’s
Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs said that they will sell generic versions of a new and highly effective HIV prevention drug for roughly $40 per year beginning in 2027. Lenacapavir, developed by Gilead Sciences and approved earlier this year for HIV prevention under the brand name Yeztugo, is a twice-yearly injection that was nearly 100% effective at preventing HIV in large trials.Tata Motors
Jaguar Land Rover Automotive Plc is trying to clear a backlog of payments owed to suppliers to ease a crisis caused by a cyberattack that’s brought the carmaker’s factories to a standstill, Bloomberg reported. The British automaker’s systems were brought down by the hack, leaving it struggling to pay suppliers — many of which are small manufacturers reliant on JLR’s business.
Lupin
Lupin announced that it has received tentative approval from the United States Food and Drug Administration (US FDA) for its Abbreviated New Drug Application for Bictegravir, Emtricitabine, and Tenofovir Alafenamide Tablets, 50 mg/200 mg/25 mg. This product would be manufactured at Lupin’s Nagpur facility in India.
as a Reliable and Trusted News SourceNewgen Software
Newgen Software Technologies (UK), a wholly owned subsidiary of Newgen Software Technologies, has executed a master service agreement with a customer for cloud hosting, software license and implementation services.